Filters

Lou Grangeon, Faisal Mohammad Amin, Hui Zhou Chen, Wietse Wiels, Marta Waliszewska-Prosół, Emily Stanyer, Umberto Pensato, Dilara Onan, Karol Marschollek, Hannah Lyons, Cédric Gollion, Silvia Favaretto, Fatemeh Farham, Ruben W A van Drie, Hannah Creeney, Deirdre M Boucherie, Linda Al-Hassany

The journal of headache and pain 2023;24(1):76

Free Full Text

Abstract

The brain's master circadian clock: implications and opportunities for therapy of sleep disorders.

Prasanth Manthena, Phyllis C Zee

Sleep medicine reviews 2007;11(1):59-70

Full Text

Abstract

Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.

Faisal Mohammad Amin, Song Guo, Anne Luise Haulund Vollesen, Young Bae Lee Hansen, Erik Frandsen, Malene Rohr Andersen, Jan Fahrenkrug, Jes Olesen, Messoud Ashina

Cephalalgia : an international journal of headache 2017;37(2):136-147

Full Text

Abstract

Molecular basis of major psychiatric diseases such as schizophrenia and depression.

Masaya Tohyama, Shingo Miyata, Tsuyoshi Hattori, Shoko Shimizu, Shinsuke Matsuzaki

Anatomical science international 2016;90(3):137-43

Full Text

Abstract

Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.

Hashmat Ghanizada, Mohammad Al-Mahdi Al-Karagholi, Nanna Arngrim, Mette Mørch-Rasmussen, Matias Metcalf-Clausen, Henrik Bo Wiberg Larsson, Faisal Mohammad Amin, Messoud Ashina

The journal of headache and pain 2020;21(1):19

Free Full Text

Abstract

Results: 1 – 14 / 14

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Pituitary Adenylate Cyclase-Activating Polypeptide""[mesh_terms]

Parkinson disease: Protective role and function of neuropeptides.

Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.

Global Epidemiology, Clinical Features, Diagnosis and Current Therapeutic Novelties in Migraine Therapy and their Prevention: A Narrative Review.

Neuropeptides and diabetic retinopathy.

Emerging experimental drugs in clinical trials for migraine: observations and key talking points.

Effect of K channel blocker glibenclamide on PACAP38-induced headache and hemodynamic.

Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV.

Synergistic effects of two naturally occurring iridoids in eliciting a rapid antidepressant action by up-regulating hippocampal PACAP signalling.

Molecular dynamics (MD) simulations of VIP and PACAP27.

Future targets for migraine treatment beyond CGRP.

The brain's master circadian clock: implications and opportunities for therapy of sleep disorders.

Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.

Molecular basis of major psychiatric diseases such as schizophrenia and depression.

Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.

Results for

""Pituitary Adenylate Cyclase-Activating Polypeptide""[mesh_terms]